UPDF AI

Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression.

J. Vionnet,Jorge Torres-Yaguana,29 Authors,A. Sánchez-Fueyo

2024 · DOI: 10.1016/j.ajt.2024.12.002
American Journal of Transplantation · 5 Citations

TLDR

The biomarker test did not yield useful information in selecting patients able to successfully discontinue immunosuppression, and operational tolerance was associated with time post-transplantation, recipient age, presence of circulating exhausted CD8+ T cells, and a reduced number of immune synapses within the graft.